Order or notice
Maharashtra FDA cancels Inducare Pharma's licence (Aug 2026)
Last checked 10 October 2026
Maharashtra FDA cancelled the manufacturing licence of Inducare Pharma Pvt Ltd, Jejuri, on 8 Aug 2026 after fungus, insects and larvae were found in six of its products; ten Inducare products also appear in the FDA's table of failed lab tests.
- Classification
- Licence suspended
- Decided by
- Maharashtra Food and Drug Administration
- Reference
- Licence cancellation of 8 Aug 2026 (reported); Maharashtra FDA NSQ alerts table, as of 9 Oct 2026
- Latest action
- 8 August 2026
- Last checked
- 10 October 2026
Photo: Contemporary Ayurveda (156350019).jpeg by Hans Vivek (CC0). All photo credits.
Maharashtra FDA: not of standard quality (NSQ) alerts table
Scope. A record here does not by itself mean a product or company is unsafe or banned today. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Below: Blacklisted's explanationWe organise and explain what the document says. The document above is the authority.
Key facts
- Firm
- Inducare Pharma Pvt Ltd, Jejuri (Pune district); spelt Induscare in the FDA table
- Action
- Licence cancelled on 8 Aug 2026
- Finding
- Fungus, insects and larvae in six products (reported)
- NSQ table
- Ten Inducare products listed: Arogyavardhini, Sinhanad Guggul, Punarnavadi Mandur, Triphala Guggul, Kanchanar Guggul, Hingvashtak Churna, Triphala Churna, Tribhuvankirti, Shwasakuthar, Sootshekhar
- Reasons in the table
- Fungus, microbial and 'description'
Maharashtra FDA cancelled the manufacturing licence of Inducare Pharma Pvt Ltd of Jejuri, Pune district, on 8 Aug 2026. The Bridge Chronicle reported that fungus, insects and larvae had been found in six of its products.
Maharashtra FDA's table of products that failed state lab tests, as of 9 Oct 2026, lists ten products of the firm, which the table spells 'Induscare': Arogyavardhini, Sinhanad Guggul, Punarnavadi Mandur, Triphala Guggul, Kanchanar Guggul, Hingvashtak Churna, Triphala Churna, Tribhuvankirti, Shwasakuthar and Sootshekhar. The reasons given are fungus, microbial findings and 'description'.
The cancellation applies to this manufacturer's licence. It does not concern the ingredients or formulations in general, which other licensed makers also produce.
What this means for you
This is a firm-level action
The licence of one manufacturer was cancelled. It is not a finding about ayurvedic medicines in general or about other makers of the same formulations.
Spelling
The FDA table prints the firm as Induscare. Press reports say Inducare. Check the maker's name on the pack.
This is a record of official orders, not medical advice. Do not stop a prescribed medicine without asking your doctor or pharmacist.
Common questions
Does the cancellation affect other brands selling the same medicines?
No. It applies to Inducare Pharma's licence. Other makers hold their own licences.
Official sources and primary records
- Pune ayurvedic medicine: fungus, insects, larvae found; FDA cancels licenceNewsThe Bridge Chronicle
- Maharashtra FDA: not of standard quality (NSQ) alerts tableRegulatorMaharashtra Food and Drug Administration · 9 October 2026